- Global Biotechnology Company | CSL
CSL has delivered biotechnology excellence for over a century Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need
- Global Biotechnology Company | CSL
Our parent company, CSL, headquartered in Melbourne, Australia, employs more than 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries
- We Are CSL | CSL
Since our start in 1916, we have been driven by our promise to save lives using the latest technologies Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000 people
- Our Businesses and Products | CSL
CSL is committed to protecting public health and improving and saving the lives of patients with rare and serious diseases through the development, manufacture and reliable supply of high-quality medicines
- Global Biotechnology Company | CSL
Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St Gallen, Switzerland
- Global Newsroom | CSL
Recent News Releases Featuring releases from CSL, CSL Behring, CSL Seqirus and CSL Vifor
- Global plasma collector | CSL
CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with nearly 330 plasma donation centers globally, including the U S and Europe and employs nearly 16,000 employees
- Financial Results and Information | Global Biotechnology Company | CSL
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor Together they help ensure people everywhere get the treatments they need
|